HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

In vivo inhibition of endotoxin-induced pro-inflammatory cytokines production by the sigma ligand SR 31747.

Abstract
In previous studies, the authors demonstrated that the new sigma ligand, cis-N-cyclohexyl-N-ethyl-3-(3-chloro-4-cyclohexyl-phenyl) propen-2-ylamine hydrochloride (SR 31747), elicited a suppressive effect on immune responses through the sigma receptor expressed on lymphocytes. Here the effect of SR 31747 on the proinflammatory cytokine production by endotoxin-activated macrophages is examined. In vivo, SR 31747 dramatically blocked lipopolysaccharide-induced production of interleukin (IL)-1, IL-6 and tumor necrosis factor-alpha in a dose-dependent manner (ED50, 2 mg/kg). Whereas SR 31747 suppression was not observed in vitro on lipopolysaccharide-induced IL-6 by macrophages, sera from SR 31747-treated animals displayed a strong inhibitory activity. It was shown that this effect could be completely reversed by the steroid receptor antagonist, mifepristone, which suggests that SR 31747 probably abrogated monokine production through an indirect mechanism that involves endogenous corticosteroids. This conclusion was supported by in vivo experiments that showed that 1) ablation of corticosteroids by use of mifepristone or adrenalectomy suppressed the effect of SR 31747 and 2) administration of SR 31747 induced an enhancement of the corticosterone level. It was also shown that this molecule improved the survival of animals with endotoxinic shock as a result of monokine inhibition. The combination of immunosuppression, previously described, along with anti-inflammatory properties makes SR 31747 a novel attractive molecule for therapeutic applications such as autoimmune diseases in which both immune and inflammatory disorders are involved.
AuthorsJ M Derocq, B Bourrié, M Ségui, G Le Fur, P Casellas
JournalThe Journal of pharmacology and experimental therapeutics (J Pharmacol Exp Ther) Vol. 272 Issue 1 Pg. 224-30 (Jan 1995) ISSN: 0022-3565 [Print] United States
PMID7815336 (Publication Type: Journal Article)
Chemical References
  • Anti-Inflammatory Agents, Non-Steroidal
  • Cyclohexanes
  • Endotoxins
  • Interleukin-1
  • Interleukin-6
  • Lipopolysaccharides
  • Receptors, sigma
  • Tumor Necrosis Factor-alpha
  • Mifepristone
  • SR 31747
Topics
  • Adrenalectomy
  • Animals
  • Anti-Inflammatory Agents, Non-Steroidal
  • Cyclohexanes (pharmacology)
  • Endotoxins (pharmacology)
  • Female
  • Interleukin-1 (metabolism)
  • Interleukin-6 (metabolism)
  • Lipopolysaccharides (pharmacology)
  • Macrophages, Peritoneal (drug effects, metabolism)
  • Male
  • Mice
  • Mice, Inbred BALB C
  • Mifepristone (pharmacology)
  • Rats
  • Rats, Sprague-Dawley
  • Receptors, sigma (drug effects)
  • Shock, Septic (prevention & control)
  • Tumor Necrosis Factor-alpha (metabolism)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: